Key facts
| Recalling firm | CareFusion 213, LLC |
|---|---|
| Manufacturer | CareFusion 213, LLC |
| Brand name | CHLORAPREP ONE-STEP |
| Product description | BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), packaged as a) 100 x 10.5 mL applicators/case, NDC 54365-400-35, Catalog Number: 930715NS; b) 100 x 10.5 mL applicators/case, Catalog Number bulk 930715NSB, NDC 54365-400-35; STERILE SOLUTION, CAREFUSION 213, LLC, EL PASO, TX 79912, subsidiary of Beckton, Dickson and Co. |
| Classification | Class II |
| Recall number | D-0643-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), packaged as a) 100 x 10.5 mL applicators/case, NDC 54365-400-35, Catalog Number: 930715NS; b) 100 x 10.5 mL applicators/case, Catalog Number bulk 930715NSB, NDC 54365-400-35; STERILE SOLUTION, CAREFUSION 213, LLC, EL PASO, TX 79912, subsidiary of Beckton, Dickson and Co. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from CareFusion 213, LLC. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from CareFusion 213, LLC should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to CareFusion 213, LLC directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
CareFusion 213, LLC’s FDA history
Argus HQ has recorded 17 total FDA actions tied to CareFusion 213, LLC: 1 warning letter, 16 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconat recalled?
- Yes. FDA lists a Class II recall by CareFusion 213, LLC for BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), packaged as a) 100 x 10.5 mL applicators/case, NDC 54365-400-35, Catalog Number: 930715NS; b) 100 x 10.5 mL applicators/case, Catalog Number bulk 930715NSB, NDC 54365-400-35; STERILE SOLUTION, CAREFUSION 213, LLC, EL PASO, TX 79912, subsidiary of Beckton, Dickson and Co., reported 20260708, with status "Ongoing." FDA recall number: D-0643-2026.
- What is the recall class for CareFusion 213, LLC's recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Why was BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconat recalled?
- FDA's recall record states the reason as: Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for CareFusion 213, LLC- Recall: CareFusion 213, LLC — Class II recall: BD PurPrep, (Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl a… →
- Recall: CareFusion 213, LLC — Class II recall: BD ChloraPrep Scrub Teal, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isop… →
- Recall: CareFusion 213, LLC — Class II recall: BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl… →
- Recall: CareFusion 213, LLC — Class II recall: BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v… →
- Recall: CareFusion 213, LLC — Class II recall: BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v… →
- Recall: CareFusion 213, LLC — Class II recall: BD ChloraPrep CLear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl… →
- Recall: CareFusion 213, LLC — Class II recall: ChloraPrep FREPP, Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopr… →
- Recall: CareFusion 213, LLC — Class II recall: BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG), and 70% v/v isopropy… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class II Recall: CHLORAPREP ONE-STEP by CareFusion 213, LLC — Recall Details. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/carefusion-213-d-0643-2026-2026-07-08
"FDA Class II Recall: CHLORAPREP ONE-STEP by CareFusion 213, LLC — Recall Details." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/carefusion-213-d-0643-2026-2026-07-08.
Argus HQ Research. "FDA Class II Recall: CHLORAPREP ONE-STEP by CareFusion 213, LLC — Recall Details." Digital Empire Holdings LLC. Accessed July 24, 2026. https://argushq.ai/recall/carefusion-213-d-0643-2026-2026-07-08.
@misc{argushq_argushq_ai_recall_carefusion_213_d_0643_2026_2026_07_08_2026,
title = {FDA Class II Recall: CHLORAPREP ONE-STEP by CareFusion 213, LLC — Recall Details},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/carefusion-213-d-0643-2026-2026-07-08},
note = {Accessed: July 24, 2026}
}Source: FDA.gov — Recalls ↗

